June 12, 2019 Cell Analysis Tools PR/Corporate Product Launch

Excelitas to Highlight New Cytometry Solutions at CYTO Vancouver

JUNE 12, 2019  WALTHAM, MA Who: Excelitas Technologies®, a global technology leader delivering innovative, customized photonic solutions, will showcase its latest solutions for cytometry applications at CYTO Vancouver. What: Featured products at the Excelitas booth #521 include: iFLEX-iRIS™ Compact Diode CLM Lasers and Single-Mode Fibers: Rising from our Qioptiq photonics heritage, iFLEX-iRIS CLM Lasers are a compact, high-performance,... Read more

June 11, 2019 M&A, Partnerships PR/Corporate

Nalgene Outdoor Partners with Outdoor Retailer to Help Eliminate Single Use Plastic Bottles at Summer Market, Outdoor Industry's Largest Trade Show

Nalgene Outdoor Partners with Outdoor Retailer to Help Eliminate Single Use Plastic Bottles at Summer Market, Outdoor Industry’s Largest Trade Show Official Bottle of Event Promotes “Reuse to Reduce” Lifestyle to 25,000+ Attendees ROCHESTER, N.Y., June 11, 2019 /PRNewswire/ — Nalgene Outdoor will be the “Official Bottle” of Outdoor Retailer Summer Market in 2019. Through an exclusive partnership,... Read more

June 10, 2019 Acad, Gov/Utilities PR/Corporate Product Launch

Xylem’s new ‘Decision Intelligence’ paper presents six comprehensive strategies to transform the economics of utility water management

New Xylem publication discusses how decision intelligence enables utilities to secure a sustainable, resilient and affordable water future DENVER–(BUSINESS WIRE)–Jun. 10, 2019– As global water challenges intensify, new approaches are needed to create a step change improvement in water system performance. Today at ACE19, global water technology company, Xylem (NYSE: XYL) unveiled a new publication... Read more

June 5, 2019 Acad, Gov/Utilities PR/Corporate Product Launch

Fernando Vergas appointed new Vice President of WITec Instruments Corporation

WITec GmbH, leading manufacturer of Raman and scanning-probe microscopes, has named Dr. Fernando Vargas as Vice President of WITec Instruments Corporation, its USA-based subsidiary, and Area Manager of the USA market. As a longtime WITec team member with a background in physics, Vargas has extensive experience in both the scientific application and strategic sales of... Read more

June 5, 2019 PR/Corporate

Xylem to attend the Stifel 2019 Cross Sector Insight Conference

RYE BROOK, N.Y.–(BUSINESS WIRE)–Jun. 5, 2019– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today that its Vice President, Water Utilities, Ron Askin, and its Senior Director, Investor Relations, Matt Latino, will participate in small group meetings at the Stifel 2019 Cross Sector... Read more

June 4, 2019 Cell Analysis Tools PR/Corporate

Oncology Researcher Andrew Quong Joins Fluidigm as Chief Science Officer

SOUTH SAN FRANCISCO, Calif., June 04, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) today announced that Andrew Quong, PhD, has joined the company as its first-ever Chief Science Officer.  Quong will lead the company’s strategy for the generation of bold scientific insights in immunology, immuno-oncology and other frontiers of human health based on Fluidigm® technology. He will develop and integrate Fluidigm’s science... Read more

June 4, 2019 PR/Corporate

BD Announces Pricing and Upsizing of Tender Offers

FRANKLIN LAKES, N.J., June 4, 2019 /PRNewswire/ — Becton, Dickinson and Company (NYSE: BDX) (the “Company” or “BD“) today announced the consideration payable in connection with its previously announced tender offers to purchase for cash, in the order of priority set forth in the table below, up to the applicable Tender SubCap, if any, of each... Read more

June 4, 2019 Bio/Pharma/CRO PR/Corporate Product Launch

Pivotal phase III CLL14 results for Venclexta/Venclyxto in combination with Gazyva/Gazyvaro for chronic lymphocytic leukaemia presented at ASCO 2019 and published in the New England Journal of Medicine

Basel, 04 June 2019 Pivotal phase III CLL14 results for Venclexta/Venclyxto in combination with Gazyva/Gazyvaro for chronic lymphocytic leukaemia presented at ASCO 2019 and published in the New England Journal of Medicine Venclexta/Venclyxto plus Gazyva/Gazyvaro showed improvements across multiple efficacy measures compared to Gazyva/Gazyvaro plus chlorambucil, including progression-free survival and deep remissions as determined by... Read more